EUVIMEDEUVIMED entdecken
Crossref

Equine sarcoids. Part 2: potential diagnosis pitfalls

Christoph Koch

UK-Vet Equine · 02.07.2026 · 10 (4) · 146-151

DOI: 10.12968/ukve.2025.0028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift UK-Vet Equine, erschienen am 02.07.2026. Verfasst von Christoph Koch. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Equine sarcoids are the most common cutaneous neoplasm of equids and are characterised by marked variability in clinical appearance, biological behaviour and treatment response, creating substantial diagnostic and therapeutic challenges. Clinically, sarcoids may present as occult, verrucous, nodular, fibroblastic, mixed or malevolent forms and frequently mimic other dermatological conditions. Consequently, clinical diagnosis alone achieves only approximately 80% sensitivity and specificity, with false-positive diagnoses being the most common error. Accurate diagnosis is critical, as sarcoids are often managed using costly and potentially aggressive therapies. While histopathology remains the diagnostic gold standard, concerns persist regarding biopsy-associated lesion exacerbation and occasional inconclusive results. Hence, polymerase chain reaction detection of bovine papillomavirus DNA from swabs, scrapings or fine-needle aspirates represents a valuable adjunct or alternative diagnostic tool, particularly when biopsy is undesirable, such as in research settings, or when histopathological findings are equivocal. Therapeutically, no single treatment modality is universally effective. Current options include surgical excision or physical destruction, local chemotherapy and immunotherapy, with multimodal strategies frequently improving outcomes, especially for extensive disease or lesions in tissue-sensitive locations. Treatment decisions should be individualised, considering lesion type, anatomical location, patient age and disease progression. Importantly, spontaneous regression may occur, particularly in young horses with few, stable lesions, supporting a carefully selected and actively monitored wait-and-see approach in specific cases. Long-term success relies heavily on proactive owner involvement, including diligent monitoring of treated sites, early recognition of recurrence and timely communication to enable prompt follow-up intervention.

Zitieren

APA

Koch, C. (2026). Equine sarcoids. Part 2: potential diagnosis pitfalls. UK-Vet Equine, 10(4), 146-151. https://doi.org/10.12968/ukve.2025.0028

Vancouver

Koch C. Equine sarcoids. Part 2: potential diagnosis pitfalls. UK-Vet Equine. 2026;10(4):146-151. doi:10.12968/ukve.2025.0028

BibTeX
@article{Koch2026,
  author = {Koch, Christoph},
  title = {Equine sarcoids. Part 2: potential diagnosis pitfalls},
  journal = {UK-Vet Equine},
  year = {2026},
  volume = {10},
  number = {4},
  pages = {146--151},
  doi = {10.12968/ukve.2025.0028}
}
Kostenlos starten →